Of note, the equal IL-9 and IL-5 production in the CLA− T-cell coculture is of particular interest since anti-IL-5 therapy has proven to be successful in extracutaneous allergic diseases such as asthma [44], but not in AD [45], considered a CLA+-driven disease [30]. The gene discussed is IL9; the disease is allergic disease.